Dr. Mark Thornton, in a recent Wall Street Journal op-ed, wrote that Senator Charles Grassley, "is demanding a full-scale review of each and every product ever approved," and is asking for a rejudgment by GAO "to ensure that drugs approved on surrogate endpoints are both safe and effective."
Which caused the following clarification from the senior senator from
"Surrogate end points are a valid way for the FDA to approve drugs."
Thanks to Mark (a CMPI board member), Senator Grassley was forced to admit that 21st century science is appropriate for the regulation of 21st century medicines.
When it comes to advancing the public health, there shouldn't be any room for political rhetoric.
(But, alas, we live in the real world. All the more reason to call it like we see it.)
